How the Lowly Mouse Ruined an Entire Field of Biomedicine

How one rodent rules the lab.
Feb. 13 2013 6:01 PM

Septic Shock

Years of research into inflammatory disease, costing billions of dollars in research funding, has been wasted on the lowly mouse.

black-6
The Black-6 mouse

Courtesy of Charles River Laboratories International

If you inject a person with a bolus of bacteria, she might get a fever. Her heart rate could go up, and her breathing might start to quicken. Left unchecked, there's a chance her body would succumb to inflammation, her organs failing as she dies.

Do the same to a laboratory mouse, and something unexpected happens: The cells of its tiny immune system don't get so overcharged. The animal gets the opposite of a fever; its temperature begins to drop. A modest squirt of toxin from E. coli can put a human into shock, but the relative dose must be increased a million times before it kills a mouse.

Given this divergence, you might expect that scientists who study acute inflammation might look at other animals instead. Some mammal species—rabbits, guinea pigs, or marmosets, to name a few—are more sensitive to sepsis. They're more reminiscent of us. Yet in this field of research, as in all of biomedicine, the lab mouse reigns supreme.

Daniel Engber Daniel Engber

Daniel Engber is a columnist for Slate

The perils of the murine monoculture in science have been made apparent once again, this time in a study published this week in the Proceedings of the National Academy of Sciences. The paper's authors, led by Junhee Seok, H. Shaw Warren, and Alex Cuenca, start with a dispiriting review of their colleagues' findings. So far, nearly 150 potential treatments for severe inflammation—caused by infection, burns or trauma, among other things—have been tested in clinical trials. These interventions have emerged from a sprawling literature of animal experiments—lab tests run on mice that have been injected with a bacterial endotoxin, scalded with hot water, or opened at the abdomen and relieved of a major portion of their blood supply. Yet none of the drugs that seemed so promising in model mice worked out so well in practice. Not a single human trial ended in a positive result.

Advertisement

That doesn't mean that animal testing is itself a lousy business, but it does imply that the animals in question might not be the best candidates for the job. The new study provides the details to support this crucial notion. To assess the mouse as a model for inflammation, the authors performed all the procedures described above and analyzed the animals' white blood cells for changes in the activity of their genes. Then they did the same for human patients, by comparing blood-cell samples drawn from healthy people to those from people suffering from the analogous diseases (inflammation brought on by burns or trauma, or in some experimental conditions, by injection with the endotoxin). Finally, the scientists placed the mouse and human data side by side. How similar, in fact, were the genes involved in each species' inflammation? Which molecules or kinds of signaling inside a cell did these two systems share?

The answer: not many. The correlation between mice and people was close to zero. For any given human gene that kicked up its activity or battened down in response to inflammation, there was a 50-50 chance that a corresponding mouse gene would be moving in the same direction. Even when the experimenters limited their analysis to the "top 105" genes most obviously implicated in human inflammation—the ones they found to have the most significant changes overall—the study found only weak corroboration in the mice.

The differences went deeper still. Those changes the researchers found in human patients persisted for many months after whatever happened to cause the inflammatory response. In mouse models, these changes tended to resolve within a couple of days. Not only did the individual genes that respond to inflammation differ across the species, so did the major pathways for communication within cells. It wasn't only that the human and mouse immune systems were driving different cars, or driving them at different speeds: They were driving on different roads, and heading in different directions altogether.

Another surprise was that the gene data from the humans looked the same across a motley set of patients: Burn victims had very similar patterns of gene activation to those who had suffered trauma, and they weren't far off from the patients who had been injected with bacterial toxins. That held true even though the patients in each subgroup were themselves a mix of men and women, old and young, with conditions of varying extent and severity. (Some burn victims had suffered damage to over three-quarters of their skin, for example, while others had burned one-third.)

Among the mice, though, the genetic data didn't match so well across the experimental conditions. The animals that had been burned reacted not at all like the ones that had been blood-let or injected with the toxin. That's despite the fact that unlike the humans, every mouse was pretty much the same as every other: an 8-week-old, male specimen of the C57Bl/6 ("Black-6") strain that has become the standard currency in biomedical research. Black-6 mice are not merely members of a family: They are inbred to the point that each one can be described as an identical twin to every other, in a sprawling lineage of virtual clones that dates back 90 years. It's not just genetics, either. These 8-week-old, male Black-6 mice were raised under identical conditions, in mostly germ-free environments on beds of aspen chips, with little opportunity for exercise and an endless supply of food. Even still, the human data looked far more consistent across conditions than did data from the mice.

Taken together, the findings suggest a fundamental disconnect between the mouse models of inflammation and what occurs in human patients. It's not just that mice might have an attenuated response to trauma and infection, but that their response differs in important, qualitative ways from our own. In humans, trauma and infection (and many other conditions) can lead to the same dangerous endpoint—an outcry from the immune system known as systemic inflammatory response syndrome. In mice, something else may be happening altogether.

This isn't the first time, of course, that researchers have dipped their toes into the gulf that separates the genes of mice and men. Another PNAS paper, published five years ago by Ben-Yang Liao and Jianzhi Zhang, compared "essential" genes in mice and humans—the bits of DNA code that, if tweaked and inactivated, lead to early death or infertility. Liao and Zhang identified 120 genes that are vital for human survival, and of these just 93 turned out to be essential in mice. "It is possible that mouse models of a large number of human diseases will not yield sufficiently accurate information," they wrote in their conclusion, "although they might provide some basic knowledge."

  Slate Plus
Working
Dec. 18 2014 4:49 PM Slate’s Working Podcast: Episode 17 Transcript Read what David Plotz asked a middle school principal about his workday.